Table III.

The expression of miR-140-3p/miR-140-5p in SF of each group, presented as mean (sd; range)

Group	miR-140-3p	miR-140-5p
	2-ΔΔCT	2-ΔΔCT
Control	1.07 (0.43; 0.59 to 1.972)	1.08 (0.47; 0.624 to 1.879)
GA	0.82 (0.24; 0.529 to 1.214)	0.85 (0.25; 0.48 to 1.206)
RA	0.86 (0.39; 0.308 to 1.464)	0.8 (0.33; 0.382 to 1.24)
Mild OA	0.274 (0.13; 0.086 to 0.54)*	0.36 (0.275; 0.14 to 1)†
Moderate OA	0.132 (0.086; 0.021 to 0.299)*	0.173 (0.102; 0.09 to 0.356)‡
Severe OA	0.031 (0.019; 0.008 to 0.08)*	0.036 (0.031; 0.013 to 0.117)*

^*Significant difference in the marked group compared with the other groups

^†Significant difference in the marked group compared with the control, GA, RA, and severe OA groups

^‡Significant difference in the marked group compared with the control, GA, RA, and severe OA groups, p < 0.05

ΔΔCT = [(CT_{miR-140-3p/5p} - CT_U6)group - (CT_{miR-140-3p/5p} - CT_U6)control], 2^-ΔΔCT = log transformed ΔΔCT, the fold change in miR-140-3p or miR-140-5p expression normalised to U6 and relative to control

CT, threshold cycle; GA, arthritis due to gout; RA, rheumatoid arthritis; OA, osteoarthritis